Recent Financing
Recent Raise
Sirius Therapeutics develops siRNA therapeutics and RNA delivery technologies for cardiometabolic disorders, operating three clinical-stage programs (SRSD107 Phase 2 Europe, SRSD216 and SRSD101 Phase 1) and a preclinical pipeline.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
